Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 73 publications.

Davis KL, Manjunath R, Ettinger AB. The association between attention deficit and psychiatric disorders and adherence to antiepileptic drug treatment in pediatric epilepsy. Poster presented at the 62nd Annual Meeting of the American Epilepsy Society; December 2008.

Chang JE, Medlin SC, Kahl BS, Longo WL, Williams EC, Lionberger J, Kim K, Kim J, Esterberg E, Juckett MB. Augmented and standard Berlin-Frankfurt-Munster chemotherapy for treatment of adult acute lymphoblastic leukemia. Leuk Lymphoma. 2008 Dec;49(12):2298-307. doi: 10.1080/10428190802517732

Gidal BE, Candrilli SD, Davis KL, Manjunath R. The association between antiepileptic drug and hmg-coa reductase inhibitor interactions and health outcomes in epilepsy. Poster presented at the 62nd Annual Meeting of the American Epilepsy Society; December 2008.

Mitra D, Candrilli SD. Inpatient costs and outcomes associated with hepatitis c, human immunodeficiency virus, and co-infection with both in the United States. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 8, 2008. [abstract] Value Health. 2008 Nov; 11(6):A440-1.

Mitra D, Davis KL, Medjedovic J, Beam C, Rustgi V. The economic burden of hcv and hbv co-infection: evidence from United States managed care data. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A440.

Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi V. Variation in direct medical costs by disease severity among persons with chronic hepatitis c virus. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A335-6.

Wolowacz SE, Roskell NS, Maciver F, Beard SM, Robinson P, Plumb J. Cost-effectiveness of dabigatran etexilate for the primary prevention of venous thromboembolism in patients undergoing total hip or total knee replacement surgery. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A404.

Candrilli SD, Davis KL, Balkrishnan R. Inpatient length of stay and total costs of illnesses of pressing concern for Asian-American and Pacific Islander women in the United States. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece. [abstract] Value Health. 2008 Nov; 11(6):A424. Previously presented at the 3rd Annual Asia-Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research.

Candrilli SD, Roberts C, Classi P. Changes in cardiovascular events and procedures from 2000-2005. Poster presented at the American Heart Association's 2008 Scientific Sessions; November 2008.

Mladsi DM, Palmer WN, Miller D. Threshold pricing analysis: an economist's contribution to pharmaceutical pricing. Presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.

Mladsi DM, Irish WD, Copley-Merriman K, Bhandary D. Statistical measures of treatment effects in oncology: what are we missing? Presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.

Brogan AJ, Everhard F, Talbird SE, Hutt E, Zimovetz E. NRTI backbone pairs for treatment-naïve adults with HIV infection: a UK economic evaluation. Poster presented at the 9th International Congress on Drug Therapy in HIV Infection; November 2008.

Brogan AJ, Everhard F, Talbird SE, Hutt E. Cost-effectiveness of tenofovir/emtricitabine compared with other NRTI pairs in treatment-naïve adults with HIV infection in the United States. Poster presented at the 9th International Congress on Drug Therapy in HIV Infection; November 2008.

Patel PA, Zyczynski TM, Beard SM, Earnshaw SR, McDade CL, Zimovetz E. A European multicountry comparison of the cost-effectiveness of iodixanol versus iohexol based on the results of the NEPHRIC clinical trial. Poster presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.

Zarkin GA, Cowell AJ, Dunlap LJ, Hicks KA, Keyes VS, Mills MJ. Simulating the costs and benefits of prison-based substance abuse treatment. Presented at the Addiction Health Services Research; October 2008.

Mitra D, Davis KL, Beam C, Medjedovic J, Rustgi V. Economic burden of hcv and hiv co-infection compared to hcv alone in a managed care population. Poster presented at the Joint Meeting of the American Society for Microbiology and Infectious Disease Society of America; October 2008.

Mitra D, Davis KL, Beam C, Medjedovic J, Rustgi V. Association between sustained virologic response and health care costs in patients with chronic hepatitis C virus: evidence from a US managed care database. Poster presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases; October 2008.

Marton JP, Jackel JL, Carson RT, Rothermel CD, Friedman M, Menzin J. Costs of skin and skin structure infections due to Staphylococcus aureus: an analysis of managed-care claims. Curr Med Res Opin. 2008 Oct;24(10):2821-8.

Davis KL, Bapat BS, Bell TJ, Miller JD. Hospital costs, length of stay, and mortality associated with meningococcal disease in the United States. Poster presented at the 2008 Infectious Disease Society of America (IDSA) Annual Meeting; October 2008.

Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi V. Real-world treatment patterns and medication costs in chronic hepatitis c: evidence from a US managed care database. Poster presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases; October 2008.

Wolowacz SE, Hess N, Brennan VK, Monz BU, Plumb JM. Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years. Curr Med Res Opin. 2008 Oct 1;24(10):2993-3006.

Farkouh RA, Earnshaw SR, Watson ME, Maroudos P. Short-term cost-effectiveness of hla*b-5701 testing prior to initiation of abacavir. Poster presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy / Infectious Disease Society of America 46th Annual Meeting; October 2008.

Brogan AJ, Mauskopf JA, Martin S, Smets E. Cost-effectiveness of darunavir for treatment experienced adults with HIV infection in the US. Poster presented at the Annual Meeting of the Institute for Operations Research and Management Science; October 2008.

Hicks KA, Zarkin GA, Cowell AJ, Dunlap LJ, Mills MJ, Keyes VS. A DES model for estimating the costs and benefits of prison-based substance abuse treatment. Poster presented at the 2008 INFORMS Annual Meeting; October 2008.

Hicks KA, Uzunangelov VJ, Lasry A, Sansom S. Allocating CDC's HIV prevention funds. Presented at the 2008 INFORMS Annual Meeting; October 2008.

Hicks KA, Richter A. Impact of uncertainty in hiv resource allocation. Presented at the 2008 INFORMS Annual Meeting; October 2008.

Graham CN, Borker R, Oppe M, Uyl-de Groot CA, Brogan AJ, Barber B. Cost-effectiveness of panitumumab plus best supportive care (BSC) compared with BSC alone in chemorefractory metastatic colorectal cancer (MCRC) patients (PTS) with wild-type (WT) KRAS tumor status in the Netherlands. Poster presented at the 33rd European Society for Medical Oncology (ESMO) Congress; September 2008.

Earnshaw SR, Graham CN, Irish WD, Sato R, Schnitzler MA. Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantation. J Am Soc Nephrol. 2008 Sep 1;19(9):1807-16.

Richter A, Hicks KA, Earnshaw SR, Honeycutt AA. Allocating HIV prevention resources: a tool for state and local decision making. Health Policy (New York). 2008 Sep 1;87(3):342-9.

Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson A, Garcia Cebrian A, Le KT. Pharmacological management of fibromyalgia in UK primary care. Poster presented at the19th Annual Clinical Meeting of the American Academy of Pain Management; September 2008. Nashville, TN.

Lee E, Candrilli SD, Roberts CS, Tang SSK, Bassin S, Wong ND. Regional Differences in the Prevalence, Treatment and Control of Hypertension and Dyslipidemia in Us Urban Hispanic Populations Participating in Health Screening Events. Ethn Dis. 2008 Sep 1;18(4):409-14.

Sikirica V, Bapat BS, Candrilli SD, Davis KL, Johns A. Inpatient care and expenditures associated with abdominal adhesiolysis in the United States in 2005. Poster presented at the VIIIth Pax meeting; September 2008.

Sunyecz J, Silberman C, Poston S, Earnshaw SR. Cost-effectiveness of ibandronate therapy for women with postmenopausal osteoporosis with respect to nonvertebral fracture efficacy. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; September 2008.

Farkouh RA, Earnshaw SR, Kauf TL, Watson ME, Maroudas P. Cost-effectiveness of hla*b-5701 testing prior to initiation of abacavir sulfate. Poster presented at the 17th International AIDS Conference; August 2008.

Fleming AD, Goatman KA, Williams GJ, Philip S, Sharp PF, Olson JA. Automated detection of blot haemorrhages as a sign of referable diabetic retinopathy. Poster presented at the MIUA 12th Annual Conference; July 2, 2008. Dundee, United Kingdom.

Javitt JC, Zlateva GP, Earnshaw SR, Pleil AM, Graham CN, Brogan AJ, Shah SN, Adamis AR. Cost-effectiveness model for neovascular age-related macular degeneration: comparing early and late treatment with pegaptanib sodium based on visual acuity. Value Health. 2008 Jul 1;11(4):563-74.

Candrilli SD, Kuznik A. The prevalence and overlap of select cardiovascular co-morbidities among US adults with dyslipidemia, by lipid-lowering medication use status. Poster presented at the 2008 Midwest Social and Administrative Pharmacy Conference; July 2008. Previously presented at the Annual Meeting of the American College of Clinical Pharmacy.

Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson AG. The pharmacological management of fibromyalgia syndrome in the UK primary care setting. Presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.

Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on opioid therapy with constipation compared to patients without constipation. Poster presented at the Annual Meeting of the Canadian Pharmacists Association; June 2008.

Tang SS, Candrilli SD, Shi L. Utilization of lipid-lowering therapy in hypertensive patients in the United States. Poster presented at the 2008 AcademyHealth Annual Research Meeting; June 2008.

Candrilli S, Balkrishnan R, O'Brien SH. The effect of injury severity on the incidence and resource utilization-related outcomes of deep vein thrombosis among pediatric trauma admissions in the United States. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A246-7.

Mitra D, Davis KL, Kotapati S, Iloeje U. Real-world treatment patterns in high-risk and metastatic melanoma: evidence from the SEER-medicare linked database. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A83.

Mitra D, Davis KL, Medjedovic J, Beam C, Rustgi VK. Health care utilization and costs associated with chronic hepatitis c in a managed care population. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A103.

Mitra D, Candrilli S, Davis KL, Bapat B. Inpatient costs and outcomes associated with chronic hepatitis c-related complications in the United States. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A107.

Mitra D, Davis KL, Kotapati S, Iloeje U. Real-world patterns of systemic therapy utilization in high risk and metastatic melanoma: evidence from the SEER-medicare linked database. Poster presented at the Annual Meeting of the American Society of Clinical Oncology; May 2008.

Davis KL, Mitra D, Kotapati S. Direct economic burden of high-risk and metastatic melanoma: evidence from the SEER-medicare linked database. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A69-70.

Davis KL, Mitra D, Medjedovic J, Beam C, Rustgi VK. Direct economic burden of chronic hepatitis c virus in a large managed care population. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A87.

Graham CN, Earnshaw SR, Raymond V. Cost-effectiveness of anidulafungin therapy in confirmed candidemia and other forms of invasive candidiasis in Canada. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 2008. [abstract] Value Health. 2008 May; 11(3):A98.

Kotapati S, Mitra D, Davis KL, Iloeje U. Predictors of treatment choice in high-risk and metastatic melanoma: evidence from linked electronic medical records and administrative claims data. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A82-3.